Taking advantage of unexpected WebCONSORT results

Area of Science:

• Clinical Trials
• Medical Research Methodology
• Scientific Reporting

Background:

• The CONSORT statement guides authors and peer reviewers to enhance clinical trial reporting and research replication.
• WebCONSORT aims to simplify author reporting by integrating relevant CONSORT extensions for specific trials.

Discussion:

• WebCONSORT demonstrated a modest, statistically insignificant improvement (0.04) in reported items, falling short of the desired 0.15 effect size.
• A significant issue identified was that approximately one-third of manuscripts selected by editorial staff were not randomized trials, despite explicit instructions.

Key Insights:

• The study found WebCONSORT did not significantly improve the proportion of reported items in clinical trial reports.
• A substantial proportion of manuscripts intended for randomized trials were misclassified, indicating potential issues in editorial selection processes.

Outlook:

• Further research is recommended to improve the accuracy of editorial staff in identifying and selecting true randomized trials.
• Enhancing the performance of editorial staff in manuscript selection is crucial for maintaining the integrity and efficiency of scientific publishing.